IN THE NEWS
PineTree Therapeutics, Inc. Secures $23.5 Million of Series A1 Funding to Develop Cutting Edge Platform Technology to Create Therapeutic Assets for Unmet Medical Needs |
June 7, 2022
PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center |
September 27, 2022